癌症患者的抗癌药物和 COVID-19 抗病毒治疗：我们可以安全使用哪些药物？
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
机构信息
Sorbonne Université, INSERM, CIC-1901 Paris-Est, CLIP(2) Galilée, Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Pharmacology, F-75013 Paris, France; Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Oncology, F-75013 Paris, France; Institut Universitaire de Cancérologie. AP-HP Sorbonne Université, Paris, France.
Sorbonne Université, INSERM, CIC-1901 Paris-Est, CLIP(2) Galilée, Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Pharmacology, F-75013 Paris, France; Institut Universitaire de Cancérologie. AP-HP Sorbonne Université, Paris, France.
出版信息
Eur J Cancer. 2020 Sep;136:1-3. doi: 10.1016/j.ejca.2020.05.027. Epub 2020 Jun 10.
Abstract
• We summarised immunosuppressing anticancer drugs which could worsen COVID 19 infections. • Other drugs were studied for drug-drug interactions with antiviral medicines. • A ready-to-use table synthesised these interactions between antiviral and anticancer drugs.
摘要
• 我们总结了可能使 COVID-19 感染恶化的免疫抑制抗癌药物。 • 研究了其他药物与抗病毒药物的药物相互作用。 • 一个现成的表格综合了抗病毒和抗癌药物之间的这些相互作用。
相似文献
1
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?癌症患者的抗癌药物和 COVID-19 抗病毒治疗：我们可以安全使用哪些药物？
Eur J Cancer. 2020 Sep;136:1-3. doi: 10.1016/j.ejca.2020.05.027. Epub 2020 Jun 10.
2
Psychopharmacology of COVID-19.新型冠状病毒肺炎的精神药理学。
Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18.
3
The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes.潜在治疗药物对新冠肺炎感染患者QT间期的影响：密切监测和纠正电解质的重要性。
Med Hypotheses. 2020 Oct;143:109847. doi: 10.1016/j.mehy.2020.109847. Epub 2020 May 16.
4
COVID-19 & antiepileptic drugs: Should we pay attention?新型冠状病毒肺炎与抗癫痫药物：我们应该关注吗？
Seizure. 2020 Aug;80:240-241. doi: 10.1016/j.seizure.2020.07.005. Epub 2020 Jul 7.
5
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective.利托那韦/洛匹那韦及其与精神科药物的潜在相互作用：从COVID-19角度看
Prim Care Companion CNS Disord. 2020 Jun 18;22(3):20com02677. doi: 10.4088/PCC.20com02677.
6
Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.与新型冠状病毒SARS-CoV-2疾病相关的皮肤表现。
Med Clin (Barc). 2020 Nov 13;155(9):414-415. doi: 10.1016/j.medcli.2020.04.057. Epub 2020 Jul 24.
7
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).一名2019冠状病毒病（COVID-19）肾移植患者存在危及生命的药物相互作用。
Transpl Infect Dis. 2020 Aug;22(4):e13286. doi: 10.1111/tid.13286. Epub 2020 Jul 14.
8
[Drug interaction monitoring of lopinavir/ritonavir in COVID-19 patients with cancer].[新冠肺炎合并癌症患者中洛匹那韦/利托那韦的药物相互作用监测]
Zhonghua Nei Ke Za Zhi. 2020 May 1;59(5):400-404. doi: 10.3760/cma.j.cn112138-20200219-00097.
9
Interactions of recommended COVID-19 drugs with commonly used psychotropics.推荐的新冠病毒治疗药物与常用精神药物的相互作用。
Asian J Psychiatr. 2020 Aug;52:102173. doi: 10.1016/j.ajp.2020.102173. Epub 2020 May 21.
10
Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation.2019年冠状病毒病（COVID-19）大流行期间肝病患者的护理原则：沙特肝病研究与移植协会的立场声明
Ann Saudi Med. 2020 Jul-Aug;40(4):273-280. doi: 10.5144/0256-4947.2020.273. Epub 2020 Aug 6.
引用本文的文献
1
Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies.吡唑并三嗪衍生物作为潜在抗SARS-CoV-2药物的药物重新利用：体外和计算机模拟研究。
BMC Chem. 2024 Jul 16;18(1):132. doi: 10.1186/s13065-024-01233-z.
2
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells.HDAC1-3 抑制可增加肺间皮和上皮细胞中 SARS-CoV-2 的复制和有性感染。
Front Cell Infect Microbiol. 2023 Dec 13;13:1257683. doi: 10.3389/fcimb.2023.1257683. eCollection 2023.
3
Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties.具有抗增殖和抗 SARS-CoV-2 性质的螺-3-吲哚啉-2-酮类化合物的开发。
Sci Rep. 2022 Aug 16;12(1):13880. doi: 10.1038/s41598-022-17883-9.
4
High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses.高通量筛选 FDA 批准药物库发现伊沙佐米是一种广谱抗虫病毒药物。
Viruses. 2022 Jun 24;14(7):1381. doi: 10.3390/v14071381.
5
Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties.合成具有潜在抗肿瘤和抗 SARS-CoV-2 性质的阿司匹林-姜黄素模拟缀合物。
Bioorg Chem. 2021 Dec;117:105466. doi: 10.1016/j.bioorg.2021.105466. Epub 2021 Nov 4.
6
3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2.3-烯基-2-氧吲哚类化合物：合成、抗 SARS-CoV-2 的增殖活性和抗病毒活性。
Bioorg Chem. 2021 Sep;114:105131. doi: 10.1016/j.bioorg.2021.105131. Epub 2021 Jun 30.
7
Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.癌症与SARS-CoV-2引发的炎症、重叠功能及药物靶向治疗
Inflammopharmacology. 2021 Apr;29(2):343-366. doi: 10.1007/s10787-021-00796-w. Epub 2021 Mar 15.
8
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group.新型冠状病毒肺炎：国家药物经济学评价中心专家组的卫生技术评估考虑因素。
Value Health. 2020 Nov;23(11):1423-1426. doi: 10.1016/j.jval.2020.09.003. Epub 2020 Oct 5.
本文引用的文献
1
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
2
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group.非艾滋病相关恶性肿瘤：多学科CANCERVIH工作组的专家共识综述及实际应用
Ann Oncol. 2016 Mar;27(3):397-408. doi: 10.1093/annonc/mdv606. Epub 2015 Dec 17.
Zotero 插件